Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Vaughn

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Paclitaxel plus carboplatin in advanced carcinoma of the urothelium: an active and tolerable outpatient regimenD J Vaughn, S B Malkowicz, B Zoltick, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2000
Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomasJ H Lee, R Whittington, N N Williams, et al.
American Journal of Clinical Oncology|June 1, 1997
A phase II study of 5-fluorouracil, leucovorin, adriamycin, and cisplatin (FLAP) for metastatic gastric and gastroesophageal junction adenocarcinoma. A Penn Cancer Clinical Trial Group and Roswell Park Cancer Institute Community Oncology Research Program TrialD J Vaughn, N J Meropol, C Holroyde, et al.
The Prostate|June 8, 2001
Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasiaS B Malkowicz, W G McKenna, D J Vaughn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 9, 2022
Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-upA V Balar, D E Castellano, P Grivas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2019
Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-upY Fradet, J Bellmunt, D J Vaughn, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Paclitaxel plus carboplatin in advanced carcinoma of the urothelium: an active and tolerable outpatient regimenD J Vaughn, S B Malkowicz, B Zoltick, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2000
Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomasJ H Lee, R Whittington, N N Williams, et al.
American Journal of Clinical Oncology|June 1, 1997
A phase II study of 5-fluorouracil, leucovorin, adriamycin, and cisplatin (FLAP) for metastatic gastric and gastroesophageal junction adenocarcinoma. A Penn Cancer Clinical Trial Group and Roswell Park Cancer Institute Community Oncology Research Program TrialD J Vaughn, N J Meropol, C Holroyde, et al.
The Prostate|June 8, 2001
Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasiaS B Malkowicz, W G McKenna, D J Vaughn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 9, 2022
Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-upA V Balar, D E Castellano, P Grivas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2019
Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-upY Fradet, J Bellmunt, D J Vaughn, et al.
Pageof 4